COTY CAMPBELL: Open Payments
NPI 1265579106 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,588 in 231 payments from 16 companies in 2025. Trend: 2023 $2,179 · 2024 $2,902 · 2025 $3,588
Food & beverage: $3,588
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $603 |
| Janssen Biotech, Inc. | 31 | $509 |
| Arcutis Biotherapeutics, Inc. | 26 | $317 |
| UCB, Inc. | 14 | $312 |
| Lilly USA, LLC | 16 | $248 |
| Regeneron Healthcare Solutions, Inc. | 12 | $229 |
| Amgen Inc. | 12 | $228 |
| Galderma Laboratories, L.P. | 28 | $207 |
| PFIZER INC. | 10 | $203 |
| GENZYME CORPORATION | 10 | $143 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Zoryve, Bimzelx, RINVOQ, OTEZLA, CIBINQO.
Industry payments across SC — which companies pay providers there.
